Online Pre-Registration Has Closed

On-site registration is still available on the day of the event. Registration is free for Temple University alumni. For all other participants a registration fee of $15 applies.

Course Overview

Recent scientific advances allow us to step in front of the disease curve, addressing illness in a more specific and “personalized” approach than ever before. Not only can we react based on our tacit knowledge of a patient, but we can predict and forecast disease. This full-day live CME course focuses on the early diagnosis and management of cardiometabolic diseases and their associated cardiovascular disease risk factors, such as dyslipidemia, atherosclerosis, and diabetes. This course will also highlight new approaches to cancer screening and prevention, as well as management of depression in patients with chronic disease. Top thought leaders and healthcare professionals will come together in this interactive educational forum on advances in disease management, which truly represent the future of medicine. Advances in imaging techniques, molecular-based understanding of disease and genetics-based treatment have improved the physician’s ability to diagnose and treat these chronic diseases, while new concepts in biomarkers and risk reduction allow practical prevention strategy implementation in every physician practice.

Course Learning Objectives

• Identify the latest advances in the use of biomarkers, imaging, and genomics for the prevention of cardiovascular disease
• Assess developing strategies for prevention of various cancers, including the use of vaccines and chemoprevention, and review current guidelines for cancer screening
• Recognize the association of increased depressive symptoms and disorders with the worsening of chronic disease states, and identify strategies for early detection and treatment of depression
• Evaluate predictors of type 2 diabetes, and how to manage cardiometabolic risk in patients with early type 2 diabetes using lifestyle intervention and pharmacotherapy
• Examine genetic screening as a viable tool for predicting specific CVD states, cancers, and diabetes
• Describe current methods for early disease intervention for dementia and osteoporosis

Target Audience

Primary care physicians, hospitalists, program directors, and specialists involved in cardiology, endocrinology, hematology/oncology, infectious diseases, and women’s health.

Accreditation Statement

Temple University School of Medicine is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to sponsor Continuing Medical Education for physicians.

Certification Statement

Temple University School of Medicine designates this educational activity for a maximum of 7 AMA PRA Category 1 Credit(s)™. Physicians should only claim credit commensurate with the extent of their participation in the activity.

Disclosure Policy

It is the policy of Temple University School of Medicine; The Albert J. Finestone, M.D. Office for Continuing Medical Education to insure balance, independence, objectivity and scientific rigor in all of its sponsored or jointly sponsored educational programs. All faculty, planning committee members and content reviewers participating in programs sponsored or jointly sponsored by Temple University School of Medicine are expected to disclose to the program audience any real or apparent conflict(s) of interest related to the content of their presentation(s).

The information presented at this CME program represents the views and opinions of the individual presenters, and does not constitute the opinion or endorsement of, or promotion by, Temple University School of Medicine, Temple University Health System or its affiliates. Reasonable efforts have been taken intending for educational subject matter to be presented in a balanced, unbiased fashion and in compliance with regulatory requirements. However, each program attendee must always use his/her own personal and professional judgment when considering further application of this information, particularly as it may relate to patient diagnostic or treatment decisions including, without limitation, FDA-approved uses and any off-label uses.

Notice

Faculty, topics, schedule, and credit hours are subject to change. Audio taping or video taping is prohibited without written permission from AcademicCME and the Temple University School of Medicine.

Accessibility Statement

If you have special needs that we can address to make your participation more meaningful and enjoyable, please contact our office at 610.687.3300.

This activity is supported by
educational grants from:
AstraZeneca
Merck

Presented by:
Temple University School of Medicine